Quick Answer
Fortress Biotech, Inc. reported Stockholders Equity of $49.87 million for the year ending 2025.
- Fortress Biotech, Inc. showed an increase of +119.3% in Stockholders Equity from 2024 to 2025.
- This data is from Fortress Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2006 to 2025 (21 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: -$44.64 million | Q1 2012: $13.45 million | Q2 2012: $33.82 million | Q3 2012: $29.13 million | Q1 2013: $26.73 million | Q2 2013: $48.56 million | Q3 2013: $87.51 million | Q1 2014: $75.49 million | Q2 2014: $72.37 million | Q3 2014: $69.26 million | Q1 2015: $60.19 million | Q2 2015: $55.88 million | Q3 2015: $53.61 million | Q1 2016: $44.57 million | Q2 2016: $35.34 million | Q3 2016: $36.63 million | Q1 2017: $47.75 million | Q2 2017: $72.27 million | Q3 2017: $36.94 million | Q1 2018: $41.65 million | Q2 2018: $43.93 million | Q3 2018: $37.77 million | Q1 2019: $20.82 million | Q2 2019: $31.87 million | Q3 2019: $25.80 million | Q1 2020: $37.23 million | Q2 2020: $60.48 million | Q3 2020: $97.11 million | Q1 2021: $105.90 million | Q2 2021: $108.28 million | Q3 2021: $92.66 million | Q1 2022: $97.86 million | Q2 2022: $77.22 million | Q3 2022: $61.67 million | Q1 2023: $37.80 million | Q2 2023: $18.51 million | Q3 2023: $16.67 million | Q1 2024: $23.03 million | Q2 2024: $17.88 million | Q3 2024: $21.16 million | Q1 2025: $22.25 million | Q2 2025: $43.92 million | Q3 2025: $55.86 million.
- Historical annual values: Fiscal year 2025: $49.87 million | Fiscal year 2024: $22.74 million | Fiscal year 2023: $22.54 million | Fiscal year 2022: $41.72 million | Fiscal year 2021: $108.67 million | Fiscal year 2020: $100.34 million | Fiscal year 2019: $26.22 million | Fiscal year 2018: $1.85 million | Fiscal year 2017: $52.57 million | Fiscal year 2016: $38.50 million | Fiscal year 2015: $56.85 million | Fiscal year 2014: $70.52 million | Fiscal year 2013: $81.28 million | Fiscal year 2012: $22.03 million | Fiscal year 2011: $19.13 million | Fiscal year 2010: -$15.90 million | Fiscal year 2009: -$15.90 million | Fiscal year 2008: $5.0 thousand | Fiscal year 2007: -$2.75 million | Fiscal year 2006: -$123.0 thousand | Fiscal year 2006: $0.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: